You have 9 free searches left this month | for more free features.

Condition

COVID-19 (1)

Carcinoma, Basal Cell (1)

Cholangiocarcinoma (1)

Multiple Myeloma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (3)

phase 1/phase 2 (1)

Sponsor

Senhwa Biosciences, Inc. (3)

Cylene Pharmaceuticals (1)

Collaborator

Intervention

cx-4945 (4)

cisplatin (1)

gemcitabine (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

cx-4945

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19 Trial in Taipei (CX-4945)

Active, not recruiting

COVID-19

CX-4945

Taipei, Taiwan

Taipei Medical University Hospital

Apr 16, 2023

Carcinoma, Basal Cell Trial in United States (CX-4945)

Recruiting

Carcinoma, Basal Cell

CX-4945

Aurora, Colorado
+3 more

Mar 11, 2022

Cholangiocarcinoma Trial in Korea, Republic of, Taiwan, United States (CX-4945, Cisplatin, Gemcitabine)

Completed

Cholangiocarcinoma

CX-4945
+2 more

Scottsdale, Arizona
+15 more

Oct 20, 2021

Multiple Myeloma Trial in United States (CX-4945)

Unknown status

Multiple Myeloma

CX-4945

Kettering, Ohio
+5 more

Jun 13, 2011